http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109748964-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2017-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109748964-B
titleOfInvention CD317 single-chain antibody 317scFv, coding sequence thereof, preparation method and application
abstract The invention provides a CD317 single-chain antibody 317scFv, a coding sequence, a preparation method and application thereof, wherein the single-chain antibody 317scFv does not depend on ADCC, directly acts on tumor cells to inhibit the growth of the tumor cells, can be used in combination with radiotherapy, chemotherapy and the like, does not contain an Fc segment, and has small molecular weight and better penetration effect.
priorityDate 2017-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008219974-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008036688-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3051
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID69550
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ811A2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6WRU0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8R2Q8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ10589
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID852675
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID684

Total number of triples: 25.